Peregrine Accepted for Poster Presentation of Cotara Trial Data At the Society of Nuclear Medicine
(Business Wire)...~~~Phase I/II Evaluation of the Therapeutic Efficacy and Safety of 131I-chTNT-1/B for Treatment of Malignant Tumors.......~~~ Cotara is Peregrine`s Tumor Necrosis Therapy (TNT) drug.......Cotara is currently being studied in a multi-center Phase II study for brain cancer....- Apr 24 8:23 AM ET
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/bw/010424/2223.html
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines